Source: PR NEWSWIRE

Press Release: Grupo Somar : Endo completes acquisition of Grupo Farmaceutico Somar®

DUBLIN, July 24, 2014 /PRNewswire/ -- Advances Endo's transformation into a leading global specialty healthcare company Establishes a platform for growth in key Latin American emerging markets Norbert Oppitz appointed Regional President, Latin America, Africa and Export Markets Endo...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
José Miguel Rodríguez Ramos's photo - CEO of Grupo Somar

CEO

José Miguel Rodríguez Ramos

CEO Approval Rating

70/100

Read more